Finance
AstraZeneca wins shareholder backing for NYSE listing in US pivot
Published by Global Banking & Finance Review®
Posted on November 3, 2025
2 min readLast updated: January 21, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on November 3, 2025
2 min readLast updated: January 21, 2026
AstraZeneca's shareholders approve a direct listing on the NYSE, enhancing access to US capital and supporting global expansion.
(Reuters) -AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool.
The drugmaker said 99.36% of votes cast in a general meeting favoured the proposal. The company needed at least 75% of votes for the resolution to pass.
AstraZeneca, London's most valuable company, outlined plans for a much-anticipated U.S. direct listing in September, replacing its existing American depositary receipts on the Nasdaq with ordinary shares on the NYSE, while retaining its London and Stockholm listings.
The U.S. market accounts for more than 40% of AstraZeneca's revenue, making it critical to CEO Pascal Soriot's growth strategy and future outlook amid mounting political scrutiny.
AstraZeneca Chair Michel Demare said in a statement that the shareholder vote in favour of the board's proposal showed strong investor confidence in the company's move to streamline its listing across London, Stockholm and New York.
He said the harmonised listing structure would give AstraZeneca greater flexibility to tap global capital markets, particularly in the U.S., as it continues to expand in high-growth regions.
While analysts and policymakers had expressed relief that the Anglo-Swedish drugmaker's plans did not include ditching its London listing altogether, there are still concerns that the move could prompt other large companies to follow suit.
The direct listing on the NYSE is expected to go live on February 2, 2026.
(Reporting by Yamini Kalia and Aatrayee Chatterjee in Bengaluru; Editing by Arun Koyyur and Tomasz Janowski)
A direct listing is a method for a company to go public by allowing its existing shares to be traded on a stock exchange without issuing new shares or raising capital.
The New York Stock Exchange (NYSE) is one of the largest stock exchanges in the world, where shares of publicly traded companies are bought and sold.
American depositary receipts (ADRs) are a way for U.S. investors to buy shares in foreign companies, representing shares of the foreign stock traded on U.S. exchanges.
Capital access refers to the ability of a company to obtain funds or financing for its operations and growth, often through equity or debt markets.
Explore more articles in the Finance category
